4//SEC Filing
Kim Jong Joseph 4
Accession 0001055726-21-000022
CIK 0001055726other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 7:05 PM ET
Size
17.9 KB
Accession
0001055726-21-000022
Insider Transaction Report
Form 4
Kim Jong Joseph
DirectorChief Executive Officer10% Owner
Transactions
- Exercise/Conversion
Restricted Stock Unit
2021-03-08−63,700→ 63,700 total→ Common Stock (63,700 underlying) - Exercise/Conversion
Restricted Stock Unit
2021-03-05−120,100→ 0 total→ Common Stock (120,100 underlying) - Tax Payment
Common Stock
2021-03-05$9.19/sh−64,230$590,274→ 1,134,183 total - Exercise/Conversion
Common Stock
2021-03-08+63,700→ 1,197,883 total - Exercise/Conversion
Common Stock
2021-03-05+120,100→ 1,198,413 total - Tax Payment
Common Stock
2021-03-08$8.91/sh−34,067$303,537→ 1,163,816 total
Holdings
- 33,775(indirect: By Son: JK1)
Common Stock
- 816,527(indirect: By Partnership)
Common Stock
- 33,563(indirect: By Daughter: EK)
Common Stock
- 33,533(indirect: By Son: JK2)
Common Stock
- 5,975(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares vested on March 5, 2019; 120,100 shares vested on March 5, 2020; 120,100 shares vested on March 5, 2021. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares vested on March 8, 2020; 63,700 shares vested on March 8, 2021; 63,700 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- [F4]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001464549
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 7:05 PM ET
- Size
- 17.9 KB